Stock listing

OTC:CHJTF CSPC Pharmaceutical Group Limited Stock

US listing (OTC) of CSPC Pharmaceutical Group Limited · home listing HKEX:1093

Follow CSPC Pharmaceutical Group Limited into a list and get an email when it puts out news.

Share price · OTC:CHJTF

$1.11 USD 0.00 (0.0%)

Close on Oct 19, 2026

Day range
$1.11 – $1.11 USDOct 19, 2026
Market value
$12.66B USDAt the close on Oct 19, 2026 · price × 11.41B shares outstanding
CSPC Pharmaceutical Group Limited logo
Ticker
OTC:CHJTF
Asset type
Stock
Exchange
OTC
Currency
USD

What changed lately

Latest news

Voluntary announcement - grant of awarded shares pursuant to the 2026 share award scheme

Oct 16, 2026

Voluntary announcement - grant of awarded shares pursuant to the 2018 share award scheme

Oct 15, 2026

Voluntary announcement - SYS6088 injection (a tri-specific antibody) obtains clinical trial approval in China

Oct 15, 2026

Voluntary announcement - SYS6062 (antibody-drug conjugate) obtains clinical trial approval in China

Oct 15, 2026

Voluntary announcement - data from Phase I clinical study of SYS6002 as monotherapy for the treatment of advanced cervical cancer presented as a rapid oral presentation at the 2026 annual global meeting of the international gynecologic cancer society (igcs 2026)

Oct 8, 2026

Voluntary announcement - latest updates from 8 clinical trials to be presented at the ESMO congress 2026

Oct 5, 2026

Monthly return of equity issuer on movements in securities for the month ended 30 September 2026

Oct 2, 2026

Voluntary announcement - results of phase III clinical study of efmedaglutide alfa injection in combination with metformin in chinese adult patients with type 2 diabetes mellitus presented in a short oral discussion at the 62nd annual meeting of the european association for the study of diabetes (easd 2026)

Sep 30, 2026

Voluntary announcement - Phase Ib clinical trial of JMT206 injection for weight management in adult patients with overweight or obesity officially initiated at the first study centre in China

Sep 29, 2026

Voluntary announcement - recombinant herpes zoster vaccine (SYS6052) obtains clinical trial approval in the U.S.

Sep 29, 2026

All CSPC Pharmaceutical Group Limited news

Decks

CSPC Pharmaceutical Group Limited on 6ix

News releases
27 in the last 12 months · 51 in all · newest Oct 16, 2026 · oldest 2020
Decks
10 decks · latest August 2026

Where CSPC Pharmaceutical Group Limited is listed

ListingExchangeCountryCurrency
HKEX:1093 石藥集團 · Home listingHKEXHong KongHKD
OTC:CSPCYOTCUnited StatesUSD
LS Exchange:548183LS ExchangeGermanyEUR
gettex:CVGgettexGermanyEUR
OTC:CHJTF · This pageOTCUnited StatesUSD
Lang & Schwarz:548183Lang & SchwarzGermanyEUR
Frankfurt:CVGFrankfurtGermanyEUR
Tradegate:CVGTradegateGermanyEUR
BMV:1093NBMVMexicoMXN
Dusseldorf:CVGDusseldorfGermanyEUR
Frankfurt:CVGUFrankfurtGermanyEUR
Hanover:CVGHanoverGermanyEUR
Munich:CVGMunichGermanyEUR
BIVA:1093NBIVAMexicoMXN
Stuttgart:CVGStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about CSPC Pharmaceutical Group Limited.